SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-003079
Filing Date
2021-11-04
Accepted
2021-11-04 16:19:46
Documents
15
Period of Report
2021-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lbph-20211104.htm   iXBRL 8-K 56916
2 EX-99.1 lbph-ex99_1.htm EX-99.1 275854
3 GRAPHIC img58896055_0.jpg GRAPHIC 11946
  Complete submission text file 0000950170-21-003079.txt   520194

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lbph-20211104_lab.xml EX-101.LAB 21973
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lbph-20211104.xsd EX-101.SCH 2948
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lbph-20211104_def.xml EX-101.DEF 14405
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lbph-20211104_pre.xml EX-101.PRE 14580
8 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20211104_htm.xml XML 4895
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40192 | Film No.: 211380287
SIC: 2834 Pharmaceutical Preparations